1. Home
  2. HTCR vs QTTB Comparison

HTCR vs QTTB Comparison

Compare HTCR & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTCR
  • QTTB
  • Stock Information
  • Founded
  • HTCR 2009
  • QTTB 2015
  • Country
  • HTCR Japan
  • QTTB United States
  • Employees
  • HTCR N/A
  • QTTB N/A
  • Industry
  • HTCR EDP Services
  • QTTB Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTCR Technology
  • QTTB Health Care
  • Exchange
  • HTCR Nasdaq
  • QTTB Nasdaq
  • Market Cap
  • HTCR 21.2M
  • QTTB 23.3M
  • IPO Year
  • HTCR 2022
  • QTTB N/A
  • Fundamental
  • Price
  • HTCR $0.75
  • QTTB $2.80
  • Analyst Decision
  • HTCR
  • QTTB Hold
  • Analyst Count
  • HTCR 0
  • QTTB 7
  • Target Price
  • HTCR N/A
  • QTTB $12.17
  • AVG Volume (30 Days)
  • HTCR 2.5M
  • QTTB 539.0K
  • Earning Date
  • HTCR 11-13-2025
  • QTTB 11-07-2025
  • Dividend Yield
  • HTCR N/A
  • QTTB N/A
  • EPS Growth
  • HTCR N/A
  • QTTB N/A
  • EPS
  • HTCR N/A
  • QTTB N/A
  • Revenue
  • HTCR $29,625,381.00
  • QTTB N/A
  • Revenue This Year
  • HTCR N/A
  • QTTB N/A
  • Revenue Next Year
  • HTCR $3.52
  • QTTB N/A
  • P/E Ratio
  • HTCR N/A
  • QTTB N/A
  • Revenue Growth
  • HTCR 72.95
  • QTTB N/A
  • 52 Week Low
  • HTCR $0.39
  • QTTB $1.35
  • 52 Week High
  • HTCR $3.38
  • QTTB $53.17
  • Technical
  • Relative Strength Index (RSI)
  • HTCR 44.23
  • QTTB 51.62
  • Support Level
  • HTCR $0.68
  • QTTB $2.55
  • Resistance Level
  • HTCR $0.90
  • QTTB $3.60
  • Average True Range (ATR)
  • HTCR 0.08
  • QTTB 0.39
  • MACD
  • HTCR -0.01
  • QTTB -0.07
  • Stochastic Oscillator
  • HTCR 26.84
  • QTTB 38.53

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Share on Social Networks: